에 대한 최신 뉴스 Viavi Solutions (NASDAQ:VIAV) 주식

Viavi Solutions

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TMCI

TXNM

VIAV

WILC

버서스 시스템즈(NASDAQ:VS)의 주가는 회사가 국제적인 입지를 성장시키기 위한 전략의 일환으로 회사가 브라질 시장으로의 확장을 발표한 후 급등했다. 버서스 시스템즈의 주가가 금요일 프리마켓 거래에서 71.2% 상승하여 $3.39에 거래되었다.

버서스 시스템즈 주식이 약 71% 상승한 이유: 프리마켓에서 움직이는 20개의 주식

Viavi Solutions Inc

VIAVID BROADCASTING INC by ViaVid Broadcasting, Inc.

Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>) rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strategy to grow its <a href="https://www.benzinga.com/quote/VS/news">international footprint</a>.
Versus Systems shares jumped 71.2% to $3.39 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) gained 49.1% to $4.25 in pre-market trading after the company announced it secured a supplier for hMPV biospecimens.</li>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) rose 33% to $27.30 in pre-market trading after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) rose 19.2% to $2.55 in pre-market trading after declining 9% on Thursday.</li>
<li>uCloudlink Group Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) gained 18.7% to $1.59 in pre-market trading. uCloudlink Group announced that it recently signed a cooperation agreement with WH Smith PLC&#8217;s InMotion Entertainment Group.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) gained 15.3% to $0.2471 in pre-market trading after gaining around 7% on Thursday.</li>
<li>TXNM Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>) gained 14.3% to $55.99 in pre-market trading.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) gained 14% to $9.40 in pre-market trading. On Monday, Treace announced preliminary, unaudited fourth quarter and full-year 2024 revenue.</li>
<li>LSI Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) rose 8.8% to $21.00 in pre-market trading. LSI Industries will issue fiscal 2025 second quarter results before the opening bell on Thursday, Jan. 23, 2025.</li>
<li>Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) gained 8.1% to $19.39 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Beasley Broadcast Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) fell 43.8% to $5.00 in pre-market trading.</li>
<li>Viavi Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) shares fell 19.3% to $8.10 in pre-market trading. Viavi Solutions will announce its fiscal second quarter 2025 financial results on Thursday, Jan. 30, 2025, after the close of market.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) fell 18.4% to $0.2566 in pre-market trading after gaining 58% on Thursday.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) shares dipped 15.9% to $12.00 in pre-market trading.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares tumbled 12.8% to $5.61 in pre-market trading.</li>
<li>G. Willi-Food International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WILC#NASDAQ">WILC</a>) shares fell 11.5% to $14.01 in pre-market trading.</li>
<li>Bicara Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>) fell 11.5% to $10.51 in today's pre-market trading after declining 8% on Thursday.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) declined 10.3% to $167.00 in pre-market trading as the company reported weaker-than-expected earnings for its fourth quarter on Thursday.</li>
<li>MiMedx Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) dipped 6.3% to $8.50 in pre-market trading.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) fell 5% to $12.60 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43049593/slb-jb-hunt-transport-and-3-stocks-to-watch-heading-into-friday">SLB, J.B. Hunt Transport And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

VIAVI Solutions Introduced The Teravm AI Ran Scenario Generator, The Evolution Of The Company's Market-leading Ran Intelligent Controller Test Platform

Tech

Aerospace Service Provider VIAVI Supplies Precision elements to NASA's Europa Clipper Mission

In the last three months, 5 analysts have published ratings on Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>), offering a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.12, along with a high estimate of $13.00 and a low estimate of $9.50. This upward trend is evident, with the current average reflecting a 17.8% increase from the previous average price target of $9.44.
<img src="https://www.benzinga.com/files/images/story/2024/1734465628_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Viavi Solutions among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$9.50</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ruben Roy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$10.50</td>
</tr>
<tr>
<td>Andrew Spinola</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$10.60</td>
<td>-</td>
</tr>
<tr>
<td>Tim Savageaux</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Neutral</td>
<td>$10.50</td>
<td>$8.25</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Viavi Solutions. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Viavi Solutions compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Viavi Solutions's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Viavi Solutions's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/VIAV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Viavi Solutions analyst ratings.</a>
<h2>About Viavi Solutions</h2>
Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.
<h3>Breaking Down Viavi Solutions's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Viavi Solutions's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -3.91%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Viavi Solutions's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -0.76%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Viavi Solutions's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.26%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.1%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.98.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Viavi Solutions Stock

WIIM

Viavi Solutions shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight, despite raising its price target from $8 to $9.50.

Morgan Stanley analyst Meta Marshall downgrades Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) from Equal-Weight to Underweight and raises the price target from $8 to $9.5.

Downgrades

Price Target

Morgan Stanley Downgrades Viavi Solutions to Underweight, Raises Price Target to $9.5

Stifel analyst Ruben Roy maintains Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Buy and raises the price target from $10.5 to $12.

Stifel Maintains Buy on Viavi Solutions, Raises Price Target to $12

Needham analyst Ryan Koontz reiterates Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on Viavi Solutionsto Hold

<ul>
<li>&nbsp;Strategic acquisition extends VIAVI's reach into aerospace, defense and industrial end markets</li>
<li>&nbsp;Broadens VIAVI's portfolio with highly complementary product offerings</li>
<li>&nbsp;Accelerates entry into high growth applications such as autonomous air, land and sea systems</li>
</ul>
CHANDLER, Ariz., Dec. 13, 2024 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4324817-1&amp;h=3067351606&amp;u=https%3A%2F%2Fwww.viavisolutions.com%2F&amp;a=Viavi+Solutions+Inc.">Viavi Solutions Inc.</a>&nbsp;(VIAVI) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>)&nbsp;today announced that it has signed a definitive agreement to acquire Inertial Labs, Inc. for initial consideration of $150 million at closing and up to $175 million of contingent consideration over four years. VIAVI intends to fund the transaction through cash on hand.
The acquisition is expected to add approximately $50 million to VIAVI's Network and Service Enablement (NSE) annual revenue in calendar year 2025 and is expected to be accretive to EPS within 12 months of closing.
The acquisition has been approved by the Board of Directors of each company and is expected to close during the first quarter of calendar year 2025, subject to certain regulatory approvals and customary closing conditions.

VIAVI Announces Strategic Acquisition Of Inertial Labs For Initial Consideration Of $150M At Closing And Up To $175M Of Contingent Consideration Over 4-Years

Windstream Wholesale And VIAVI Complete World's First 800G Transatlantic Network Trial, Spanning 8,500 KM Between Chicago And London, Using Nokia's PSI-M Platform And VIAVI's Advanced Testing Solutions To Validate Error-Free High-Speed Transmission And Service Stability

UBS analyst Andrew Spinola initiates coverage on Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Neutral rating and announces Price Target of $10.6.

Initiation

UBS Initiates Coverage On Viavi Solutions with Neutral Rating, Announces Price Target of $10.6

Enables AeroVironment's Entry into Key Segments and Strengthens Multi-Domain Capabilities
All-Stock Transaction Will Significantly Enhance Growth and Diversification

TDC NET Selects VIAVI's NITRO AIOps For Advanced, Automated End-To-End Network Monitoring Across Complex Domain

This certification enables the Xgig CXL Exerciser to qualify CXL devices for inclusion in the CXL v2.0 Integrators List, and continues VIAVI's leadership in this critical technology segment.

General

VIAVI Solutions Announced That VIAVI Xgig CXL Exerciser has received CXL 2.0 Gold Suite Certification From The Compute Express Link Consortium

AEIS

ALGM

ANET

AVGO

AWRE

BELFB

BOXL

CAMT

CGNX

CLMB

CMTL

CNXN

COHR

CSCO

DELL

DGII

DIOD

EVLV

EXTR

FFIV

FLEX

FORM

FRSH

IONQ

IPGP

KEYS

KODK

LASR

LITE

NOVT

NTAP

NTCT

NVEC

Next Technology Holding Inc. - Ordinary Shares

NXTT

OSIS

PLUS

PLXS

PMTS

PSTG

QMCO

QTWO

SANM

SCSC

SITM

TTMI

WOLF

ZBRA

Shares of companies within the broader technology sector are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

Viavi Solutions shares are trading higher after Rosenblatt raised its price target on the stock from $8.25 to $10.5 and Northland Capital Markets raised its price target from $11 to $13.

In the last three months, 4 analysts have published ratings on Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $10.62, a high estimate of $13.00, and a low estimate of $8.50. Witnessing a positive shift, the current average has risen by 3.01% from the previous average price target of $10.31.
<img src="https://www.benzinga.com/files/images/story/2024/1730487639_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Viavi Solutions by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tim Savageaux</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Neutral</td>
<td>$10.50</td>
<td>$8.25</td>
</tr>
<tr>
<td>Dave Kang</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.50</td>
<td>$9.00</td>
</tr>
<tr>
<td>Ruben Roy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$10.50</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Viavi Solutions. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Viavi Solutions compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Viavi Solutions's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Viavi Solutions's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VIAV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Viavi Solutions analyst ratings.</a>
<h2>Unveiling the Story Behind Viavi Solutions</h2>
Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.
<h3>Viavi Solutions's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Viavi Solutions's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -4.4%. This indicates a decrease in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Viavi Solutions's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -8.61%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Viavi Solutions's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -3.13%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Viavi Solutions's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.25%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Northland Capital Markets analyst Tim Savageaux maintains Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Outperform and raises the price target from $11 to $13.

Northland Capital Markets Maintains Outperform on Viavi Solutions, Raises Price Target to $13

Rosenblatt analyst Mike Genovese maintains Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Neutral and raises the price target from $8.25 to $10.5.

Rosenblatt Maintains Neutral on Viavi Solutions, Raises Price Target to $10.5

Needham analyst Ryan Koontz reiterates Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) with a Hold.

Needham Reiterates Hold on Viavi Solutions

Viavi Solutions shares are trading higher after the company issued Q2 guidance above estimates.

Viavi (VIAV) Solutions announced that it has signed a definitive agreement to acquire Inertial Labs for initial consideration of $150M at closing a...

Viavi to acquire Inertial Labs for initial consideration of $150M at closing

Viavi Solutions to acquire Inertial Labs

Needham analyst Ryan Koontz maintained a Hold rating on Viavi Solutions (VIAV – Research Report) today. The company's shares closed last Friday at ...

Needham Reaffirms Their Hold Rating on Viavi Solutions (VIAV)

Stifel raised the firm's price target on Viavi (VIAV) to $12 from $10.50 and keeps a Buy rating on the shares after the company announced a definit...

Viavi price target raised to $12 from $10.50 at Stifel

In a report released today, Meta Marshall from Morgan Stanley downgraded Viavi Solutions (VIAV – Research Report) to a Sell, with a price target of...

Viavi Solutions Faces Growth Constraints Amid Market Rebound and Acquisition Challenges

Morgan Stanley downgraded Viavi (VIAV) to Underweight from Equal Weight with a price target of $9.50, up from $8. The firm says that with the compa...

Viavi downgraded to Underweight from Equal Weight at Morgan Stanley

Viavi, CommScope downgraded as telco recovery already baked in: MS

Nvidia remains "best idea" for AI/Accelerated compute in 2025: Stifel

ClearBridge Small Cap Growth Strategy Q4 2024 Commentary

Keysight Technologies: Capitalizing On AI Demand Tailwind

ALAB

AZPN

AZTA

BLKB

CERT

CIEN

COMM

CRDO

CWAN

FOUR

HAYW

INFR

LRGE

MCHP

MPWR

MRVL

MTSI

NVDA

OSCR

PCVX

PGNY

SGRY

SHLS

SLAB

TGTX

VRNS

WING

XMTR

YLDE

ZETA

Contracts

Press Releases

VIAVI Selected to Build Open Radio Access Network Laboratory in the Philippines

Earnings

VIAVI Announces First Quarter Fiscal 2025 Results

VIAVI Xgig® Exerciser Approved for CXL® 2.0 Gold Suite Compliance Testing

VIAVI Selected by TDC NET to Enable Network Transformation with Advanced, End-to-End Automated Monitoring Across Complex Domains

VIAVI and Rohde & Schwarz Enable SKY Perfect JSAT "Universal NTN Innovation Lab"

Windstream Wholesale and VIAVI Collaborate on World's First Transatlantic 800G Network Trial

VIAVI Expands Market Reach with Strategic Acquisition of Inertial Labs

VIAVI Delivers Precision Components for NASA's Europa Clipper Mission

VIAVI Introduces TeraVM AI RAN Scenario Generator

VIAVI Announces Date for Fiscal Second Quarter 2025 Financial Results

Applied Optoelectronics, Inc. - Common Stock

Applied Optoelectronics

Adtran Holdings

Arista Networks

Aviat Networks

Calix

Ciena

Clearfield

CommScope Holding Company, Inc. - Common Stock

CommScope Hldg Co

Cisco Systems

Digi Intl

Ericsson - American Depositary Shares each representing 1 underlying Class B share

Comments

Viavi Solutions

뉴스

에 대한 최신 뉴스 Viavi Solutions (NASDAQ:VIAV) 주식

금요일, 1월 17, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌